Form 4 Tracker
Natera, Inc.
NTRA

130 insider filings · Latest: Oct 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 15, 2026Oct 17 1:35 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Sale
50,000$402.64$20.1M2,119,394(D)

View →

Oct 15, 2026Oct 15 8:18 PMMATTHEW RABINOWITZ
Proposed Sale
50,000$394.75$19.7M—

View →

Oct 1, 2026Oct 3 1:35 AMSteven Leonard ChapmanDirector, CEO AND PRESIDENT
Sale
1,273$413.31$526.1K96,926(D)

View →

Oct 1, 2026Oct 3 1:35 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Sale
3,000$414.22$1.2M106,914(D)

View →

Oct 1, 2026Oct 1 8:24 PMSTEVEN L CHAPMAN
Proposed Sale
1,273$413.31$526.1K—

View →

Oct 1, 2026Oct 1 8:04 PMSOLOMON MOSHKEVICH
Proposed Sale
3,000$414.22$1.2M—

View →

Sep 23, 2026Sep 26 1:35 AMJonathan SheenaDirector, Other
Sale
18,064$388.01$7.0M9,000(I)

View →

Sep 23, 2026Sep 23 2:58 PMSheena Jonathan
Proposed Sale
21,064$387.55$8.2M—

View →

Sep 16, 2026Sep 18 1:35 AMJonathan SheenaDirector, Other
Sale
3,150$354.19$1.1M221,314(D)

View →

Sep 15, 2026Sep 18 1:35 AMJonathan SheenaDirector, Other
Sale
6,000$350.07$2.1M224,464(D)

View →

Sep 15, 2026Sep 17 1:35 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Sale
52,000$347.29$18.1M0(I)

View →

Sep 14, 2026Sep 17 1:35 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Sale
50,000$334.76$16.7M2,175,394(D)

View →

Sep 15, 2026Sep 15 8:53 PMTINKERBELLE II TR U/A DTD 10/22/2021
Proposed Sale
2,000$350.01$700.0K—

View →

Sep 11, 2026Sep 12 1:35 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Sale
50,000$327.97$16.4M2,225,394(D)

View →

Sep 11, 2026Sep 11 8:28 PMMATTHEW RABINOWITZ
Proposed Sale
200,000$326.14$65.2M—

View →

Sep 2, 2026Sep 4 1:35 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Sale
15,160$326.89$5.0M110,859(D)

View →

Sep 1, 2026Sep 4 1:35 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Sale
3,000$320.73$962.2K126,019(D)

View →

Sep 1, 2026Sep 4 1:05 AMSteven Leonard ChapmanDirector, CEO AND PRESIDENT
Sale
1,698$320.99$545.0K98,199(D)

View →

Sep 2, 2026Sep 2 9:03 PMSOLOMON MOSHKEVICH
Proposed Sale
0—$0—

View →

Sep 1, 2026Sep 1 8:08 PMSTEVEN L CHAPMAN
Proposed Sale
1,698$320.99$545.0K—

View →

Page 1 of 15

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Oct 15, 2026Oct 17 1:35 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
50,000$10.410(D)

View →

Jun 5, 2026Jun 10 1:05 AMGail Boxer MarcusDirector
Option Exercise
11,000$22.8311,000(D)

View →

Apr 6, 2026Apr 9 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
58,292$9.590(D)

View →

Mar 31, 2026Apr 2 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
41,708$9.5958,292(D)

View →

Mar 16, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
50,000$9.59100,000(D)

View →

Mar 13, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
75,000$9.59150,000(D)

View →

Mar 12, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
75,000$9.59225,000(D)

View →

Mar 6, 2026Mar 11 1:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Option Exercise
5,598$19.680(D)

View →

Mar 2, 2026Mar 4 2:05 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Option Exercise
5,125$9.590(D)

View →

Jan 20, 2026Jan 23 2:35 AMSteven Leonard ChapmanDirector, CEO AND PRESIDENT
Option Exercise
3,386—0(D)

View →

Jan 20, 2026Jan 23 2:35 AMMichael Burkes BrophyCHIEF FINANCIAL OFFICER
Option Exercise
1,522—0(D)

View →

Jan 20, 2026Jan 23 2:05 AMJonathan SheenaDirector, Other
Option Exercise
191—0(D)

View →

Jan 20, 2026Jan 23 2:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Option Exercise
856—0(D)

View →